One drugmaker said it was committed to expanding access to naloxone for “millions of Americans” and “maintaining affordability.”
White House meets with drug firms on cost of overdose-reversal drugs
One drugmaker said it was committed to expanding access to naloxone for “millions of Americans” and “maintaining affordability.”